BackCidara Therapeutics Overview

Cidara Therapeutics Net Income

Profitability analysis for CDTX.

Quarterly Net Income

-$83.23M
↓ 435.78% YoY

As of Sep 2025

Annual Net Income (TTM)

-$159.02M
↓ 31.55% YoY

Trailing 12 months ending Sep 2025

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin